Mental Health America estimates that in 2021 57% of adults in America dealing with a mental health disorder did not receive treatment. In other words, over 26 million individuals experiencing mental health conditions were unable to access treatment. Clearly, the need for accessible mental health care in the United States has reached a crisis point.

We’re thrilled to announce that our first peer-reviewed study is now published in Frontiers in Psychiatry: Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use.

One of the defining and debilitating marks of depression is the feeling of loneliness and isolation. For many, living with depression feels like a giant dark veil has been dropped on the world — you can see others, but they can’t see you.